Krishnan Nandabalan - Director, 10%+ Owner at BioXcel Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director, 10%+ Owner
Issuer Symbol
BTAI on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Krishnan Nandabalan since 05 Feb 2025

Holdings reported by Krishnan Nandabalan for BioXcel Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 8,546,750 $22,401,886 $2.62 06 Apr 2023 Indirect
Stock Options 294,000 06 Apr 2023 Direct Common Stock
Common Stock 0 06 Apr 2023 Direct

Transactions reported by Krishnan Nandabalan for BioXcel Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.